Therapeutic plasma exchange and intravenous immunoglobulin as primary therapy for D alloimmunization in pregnancy precludes the need for intrauterine transfusion

Transfusion

Volumn 54, Issue 8, 2014, Pages 2118-2121

  Bellone, Michael ^a   Boctor, Fouad N ^a  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; FRESH FROZEN PLASMA; HEMOGLOBIN; IMMUNOGLOBULIN G; METHOTREXATE; RHESUS D ANTIBODY;

ADULT; ALLOIMMUNIZATION; ANEMIA; ANTIBODY TITER; ARTICLE; BILIRUBIN BLOOD LEVEL; BOY; CASE REPORT; COOMBS TEST; ECTOPIC PREGNANCY; FEMALE; FETAL WELL BEING; FETUS DISEASE; FLOW RATE; HEMATOCRIT; HEMOLYSIS; HUMAN; IMMUNOTHERAPY; INTRAUTERINE BLOOD TRANSFUSION; LOADING DRUG DOSE; MALE; MATERNAL D ALLOIMMUNIZATION; MEDICAL HISTORY; MIDDLE CEREBRAL ARTERY; NEWBORN; NEWBORN DISEASE; PEAK EXPIRATORY FLOW; PHOTOTHERAPY; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RETICULOCYTE COUNT; SALPINGECTOMY; UMBILICAL CORD BLOOD;

ADULT; ANEMIA, HEMOLYTIC; BLOOD FLOW VELOCITY; BLOOD TRANSFUSION, INTRAUTERINE; FEMALE; FETAL DISEASES; GESTATIONAL AGE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; MALE; MIDDLE CEREBRAL ARTERY; PLASMA EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; RH ISOIMMUNIZATION; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84906262914     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12633     Document Type: Article

References (14)

1. Bowman J,. Thirty-five years of Rh prophylaxis. Transfusion 2003; 43: 1661-1666.
2. Bowman JM, Pollock J, Penston L,. Fetomaternal transplacental hemorrhage during pregnancy and after delivery. Vox Sang 1986; 51: 117-121.
3. Martin JA, Hamilton BE, Sutton PD, et al. Births; final data for 2002. Natl Vital Stat Rep 2003; 52: 1-116.
4. Moise KJ,. Management of Rhesus alloimminization in pregnancy. Obstet Gynecol 2002; 100: 600-611.
5. Ruma MS, Moise KJ Jr, Kim E, et al. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization. Am J Obstet Gynecol 2007; 196: 138e1-1386.
6. Angela E, Robinson E, Tovey LA,. Intensive plasma exchange in the management of severe Rh disease. Br J Haematol 1980; 45: 621-631.
7. Voto LS, Sexer H, Ferreiro G, et al. Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic diease. J Perinat Med 1995; 23: 443-451.
8. Palmeira P, Quinello C, Silveira-Lessa AL, et al. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol 2012; 2012: 985646.
9. Voto LS, Mathet ER, Zapaterio JL, et al. High-dose gamma globulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease. J Perinat Med 1997; 25: 85-88.
10. Knezevic-Maramica I, Kruskall MS,. Intravenous immune globulins: an update for clinicians. Transfusion 2003; 43: 1460-1480.
11. Osanan GC, Silveira Reis ZN, Apocalypse IG, et al. Predictive factors of perinatal mortality in transfused fetuses due to maternal alloimmunization: what really matters? J Matern Fetal Neonatal Med 2012; 25: 1333-1337.
12. Verduin EP, Schonewille H, Brand A, et al. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation. Transfusion 2013; 53: 939-947.
13. De Boer IP, Zeestraten EC, Lopriore E, et al. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion. Am J Obstet Gynecol 2008; 198: 54.e1-544.
14. Ensom MH, Stephenson MD,. A two-center study on the pharmacokinetics of intravenous immunoglobulin before and during pregnancy in healthy women with poor obstetrical histories. Hum Reprod 2011; 26: 2283-2288.